KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

LifeMD (LFMD) Net Cash Flow (2016 - 2025)

LifeMD filings provide 14 years of Net Cash Flow readings, the most recent being $6.8 million for Q4 2025.

On a quarterly basis, Net Cash Flow rose 336.26% to $6.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.4 million, a 173.8% decrease, with the full-year FY2025 number at -$4.4 million, down 173.8% from a year prior.
Net Cash Flow hit $6.8 million in Q4 2025 for LifeMD, up from -$12.4 million in the prior quarter.
In the past five years, Net Cash Flow ranged from a high of $31.9 million in Q4 2021 to a low of -$16.2 million in Q1 2022.
Median Net Cash Flow over the past 5 years was $1.7 million (2024), compared with a mean of $1.3 million.
The widest YoY moves for Net Cash Flow: up 18546.01% in 2021, down 1472.52% in 2021.
LifeMD's Net Cash Flow stood at $31.9 million in 2021, then tumbled by 105.89% to -$1.9 million in 2022, then skyrocketed by 1050.99% to $17.9 million in 2023, then crashed by 91.28% to $1.6 million in 2024, then soared by 336.26% to $6.8 million in 2025.
The last three reported values for Net Cash Flow were $6.8 million (Q4 2025), -$12.4 million (Q3 2025), and $1.8 million (Q2 2025) per Business Quant data.